PanoramicaGraficoProfiloStatistiche chiaveDati finanziariNotizieSchermataTrader

TEIJIN LTD/  JP3544000007  /

gettex
12/11/2024  19:43:43 Var. -0.150 Volume Denaro12/11/2024 Lettera12/11/2024 Capitalizzazione di mercato Dividend Y. Rapporto P/E
8.350EUR -1.76% -
Fatturato: -		 8.350Quantità in denaro: 298 8.450Quantità in lettera: 298 1.62 bill.EUR - -
TeleTrader 31/05 Blackstone reportedly to buy Japan's Infocom for $1.7B
GlobeNewswire 13/05 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparath...
GlobeNewswire 09/05 Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with...
GlobeNewswire 14/02 Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
GlobeNewswire 07/02 Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire 31/01 Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for ...
GlobeNewswire 07/01 Ascendis Pharma Introduces Vision 2030
GlobeNewswire 04/12/2023 NeuroStar TMS Receives Expanded Regulatory Approval in Japan
GlobeNewswire 29/11/2023 Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan
GlobeNewswire 30/08/2023 Churchill Franklin Automotive Launches Airbag Alert News Service
Newsfile Corp 21/11/2022 The "Electrification" of the World: Battery Safety and Efficiency Demands Grow Amidst Lofty Global E...
GlobeNewswire 24/02/2022 Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
GlobeNewswire 20/12/2021 CORRECTION - MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 20/12/2021 MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 02/06/2021 Radius Health Business Update
GlobeNewswire 25/03/2021 Calling Early Stage Medtech Start Ups: Apply Now for 2021 IGNITE
GlobeNewswire 24/03/2021 Radius Health Provides Update on Abaloparatide
GlobeNewswire 25/02/2021 Radius Health, Inc.: Fourth Quarter and Full Year Results
GlobeNewswire 12/02/2021 Radius Health, Inc. Provides Abaloparatide Business Update
GlobeNewswire 05/11/2020 Radius Health, Inc.: Third Quarter 2020 Operating Results
GlobeNewswire 21/10/2020 Radius Health, Inc.: Progress Since May 2020
GlobeNewswire 21/09/2020 NeuroSigma Receives Bridge Financing from Checkmate Capital
GlobeNewswire 09/09/2020 Radius Health Announces Scientific Presentations on abaloparatide at ASBMR 2020 Annual Meeting
GlobeNewswire 10/08/2020 Radius Health Announces Second Quarter 2020 Operating Results
GlobeNewswire 27/05/2020 Pivotal Phase III trial of abaloparatide-SC in Japanese women and men with osteoporosis achieves pri...